https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Seller warrants good and clear title in
goods subject to the sale (“Product”) and that the Product conforms
at the time of shipment to a Certificate of Analysis, a Certificate of
Compliance, or a Product Specification Sheet, if any such document
exists, and other specifications signed by Seller (“Specifications”).
Thereafter, Buyer automatically approves the invoice.
6.
Buyer shall
not (re-) export or (re-) transfer or disclose, directly or indirectly,
any of the Products or Items supplied by Seller and/or any Items
incorporating or processed from such Products, in breach of any
Trade Control laws, or, in the event an export license or other
approval is required from any governmental authority or agency,
without first obtaining such license or approval.
https://www.avient.com/sites/default/files/2022-03/Avient 2022 Proxy Statement.pdf
Management has no authority to approve services performed by EY that have not
been pre-approved by the Audit Committee.
The term of any pre-approval is 12 months from the date of
pre-approval, unless the Audit Committee specifically provides for a different period.
At each meeting of the Audit Committee, the current yearʼs previously
pre-approved independent auditor fees along with any proposed revisions will be presented for approval.
https://www.avient.com/sites/default/files/2025-01/ISCC Certificate Luxembourg%2C France.pdf
The issuing Certification Body is responsible for the accuracy of this document.
Version / Date: 1 (no adjustments) / 30.12.2024
Page 1 of 2
ISCC PLUS Certificate
Certificate Number: ISCC-PLUS-Cert-PL214-26100824
Bureau Veritas Polska Sp. z o.o.
Migdałowa 4, 02-796 Warszawa, Polska
certifies that
AVIENT Luxembourg S.à.r.l
14 Avenue de l’Eguillette, 95310 Saint Ouen L’Aumône
FRANCE
(operating under a tolling agreement)
complies with the requirements of the certification system
ISCC PLUS
(International Sustainability and Carbon Certification)
This certificate is valid from 30.12.2024 to 29.12.2025.
https://www.avient.com/industries/healthcare/medical-devices-equipment
We understand the attention to detail required to balance performance, innovation, aesthetics, haptics, and regulatory approvals.
https://www.avient.com/investor-center/news/avient-announces-twelfth-consecutive-annual-increase-quarterly-dividend
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks, including recessionary conditions; the current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; our ability to continue to pay regular quarterly cash dividends, including at the increased rate, and the amounts and timing of any future dividends; information systems failures and cyberattacks; amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; the ability to obtain required regulatory approvals and otherwise consummate the proposed sale of the Distribution business; and other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation and any recessionary conditions.
https://www.avient.com/news/exclusive-sponsor-new-exhibition-area-chinaplas-2017-polyone-showcases-innovative-polymer-solutions
LactraSX is the only commercially available fully light-blocking white additive to be compliant with the latest Chinese Food Approval standards (GB).
https://www.avient.com/news/polyone-showcase-material-colorant-and-additive-innovations-chinaplas-2018
ColorMatrix™ Lactra SX Additive is the only commercially available fully light-blocking white additive to be compliant with the latest Chinese Food Approval standards (GB).
https://www.avient.com/news/connected-safer-and-smarter-polyone-collaborates-halo-smart-labs-next-gen-home-safety-devices
Stagg connected with PolyOne for help with tough UL standard testing approvals and light dispersion issues in their initial design, problems that would jeopardize a planned 2016 product launch schedule.
https://www.avient.com/news/polyone-design-and-innovation-solutions-take-center-stage-chinaplas-2019
Plenstar™ Formulations for FR Cable give telecommunication plenum applications the flame and smoke performance required to meet UL approvals.
https://www.avient.com/news/polyone-showcase-polymer-solutions-disinfectant-resistance-mdm-west-2016
With the one of the broadest medically approved polymer portfolios available in the market, we are uniquely positioned to help our medical device customers navigate material options, enabling them to create durable, long-lasting and innovative products that stand up to the most aggressive disinfectants used today,” said Cathy Dodd, vice president, Marketing at PolyOne.